List of Contents

Parenteral Packaging Market Size, Share, and Trends 2024 to 2033

Parenteral Packaging Market (By Products: Bottles, Ampoules, Vials, Prefilled Syringes, Cartridges, Others; By Drug: Small Molecules, Biologics, Vaccines, Biosimilars, Others; By Material: Glass, Polymer, PVC, Others; By Packaging:; Small Volume Parenteral, Large Volume Parenteral) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

  • Last Updated : July 2024
  • Report Code : 4643
  • Category : Packaging

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Parenteral Packaging Market 

5.1. COVID-19 Landscape: Parenteral Packaging Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Parenteral Packaging Market, By Products

8.1. Parenteral Packaging Market Revenue and Volume Forecast, by Products, 2024-2033

8.1.1. Bottles

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Ampoules

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Vials

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

8.1.4. Prefilled Syringes

8.1.4.1. Market Revenue and Volume Forecast (2021-2033)

8.1.5. Cartridges

8.1.5.1. Market Revenue and Volume Forecast (2021-2033)

8.1.5. Others

8.1.5.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Parenteral Packaging Market, By Drug

9.1. Parenteral Packaging Market Revenue and Volume Forecast, by Drug, 2024-2033

9.1.1. Small Molecules

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Biologics

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Vaccines

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

9.1.4. Biosimilars

9.1.4.1. Market Revenue and Volume Forecast (2021-2033)

9.1.5. Others

9.1.5.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Parenteral Packaging Market, By Material 

10.1. Parenteral Packaging Market Revenue and Volume Forecast, by Material, 2024-2033

10.1.1. Glass

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Polymer

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

10.1.3. PVC

10.1.3.1. Market Revenue and Volume Forecast (2021-2033)

10.1.4. Others

10.1.4.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Parenteral Packaging Market, By Packaging 

11.1. Parenteral Packaging Market Revenue and Volume Forecast, by Packaging, 2024-2033

11.1.1. Small Volume Parenteral

11.1.1.1. Market Revenue and Volume Forecast (2021-2033)

11.1.2. Large Volume Parenteral

11.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 12. Global Parenteral Packaging Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.1.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.1.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.1.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.1.5.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.1.5.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.1.5.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.1.6.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.1.6.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.1.6.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.2.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.2.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.2.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.2.5.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.2.5.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.2.5.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.2.6.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.2.6.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.2.6.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.2.7.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.2.7.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.2.7.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.2.8.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.2.8.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.2.8.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.3.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.3.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.3.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.3.5.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.3.5.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.3.5.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.3.6.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.3.6.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.3.6.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.3.7.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.3.7.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.3.7.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.3.8.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.3.8.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.3.8.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.4.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.4.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.4.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.4.5.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.4.5.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.4.5.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.4.6.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.4.6.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.4.6.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.4.7.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.4.7.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.4.7.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.4.8.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.4.8.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.4.8.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.5.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.5.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.5.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.5.5.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.5.5.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.5.5.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Products (2021-2033)

12.5.6.2. Market Revenue and Volume Forecast, by Drug (2021-2033)

12.5.6.3. Market Revenue and Volume Forecast, by Material (2021-2033)

12.5.6.4. Market Revenue and Volume Forecast, by Packaging (2021-2033)

Chapter 13. Company Profiles

13.1. Adelphi Healthcare Packaging

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Akorn, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Alcami Corporation, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Ardena Holding NV

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Becton, Dickinson and Company

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Berkshire Sterile Manufacturing

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Baxter International Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Berry Global Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Catalent Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Gerresheimer AG.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global parenteral packaging market size is expected to increase USD 57.71 billion by 2033 from USD 31.98 billion in 2023.

The parenteral packaging market is anticipated to grow at a CAGR of over 6.08% between 2024 and 2033.

The major players operating in the parenteral packaging market are Adelphi Healthcare Packaging, Akorn, Inc., Alcami Corporation, Inc., Ardena Holding NV, Becton, Dickinson and Company, Berkshire Sterile Manufacturing, Baxter International Inc., Berry Global Inc., Catalent Inc. Gerresheimer AG., Nipro Corporation, PCI Pharma Services, Schott AG, SGD Pharma, SiO2 Materials Science., Stevanato Group S.p.A, Terumo Corporation, UDG Healthcare Plc., West Pharmaceutical Services, Inc., Ypsomed Holding AG, and Others.

The driving factors of the parenteral packaging market are the growing developments in the healthcare sector and rising government initiatives for strengthening the pharmaceutical industry.

North America region will lead the global parenteral packaging market during the forecast period 2024 to 2033.

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us